The 2019 Scheele Symposium: CRISPR-Cas and gene therapy

Welcome to the Scheele Symposium in honour of the 2019 Scheele Award Laureate, Professor Emmanuelle Charpentier. The symposium focuses on various aspects of her research, including insights into the CRISPR-Cas technology, which has paved the way for development of new, effective treatments. Take this opportunity to listen to some of the world’s foremost scientists in genetic engineering.

About the award winner

Professor Emmanuelle Charpentier, head of the Max Planck Unit for the Science of Pathogens in Berlin, is a pioneer in gene regulation in pathogenic bacteria and mechanisms that involve short sequences of ribonucleic acid. She is receiving the award for her “contribution to understanding the molecular mechanism of the CRISPR-Cas9 system – a genetic tool with several applications in drug research and development”.

“Professor Charpentier is a true innovator whose research may result in a real paradigm shift in biomedical gene therapies for many, severe, genetic disorders – including cystic fibrosis, hemophilia, and certain cancer forms,” said Karin Meyer, CEO of the Swedish Pharmaceutical Society and chair of the Scheele Award nomination committee.

Confirmed speakers

Prof Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin, Germany
Dr Felicity Allen, Sanger Institute, UK
Prof Anna Cereseto, University of Trento, CIBIO, Italy
Prof Stefan Jansson, Department of Plant Physiology, Umeå University, Sweden
Dr Marcello Maresca, associate director, Discovery Sciences AstraZeneca, Mölndal, Sweden
Dr Annarita Miccio, Imagine Institute of genetic diseases, Sorbonne Paris Cité University, France
Prof Dr Rotem Sorek, Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
Prof Dr Jörg Vogel, Institute Molecular Infection Biology, University of Würzburg, Germany
Prof Dr Eckhard Wolf, Gene Centre and Department of Biochemistry, Ludwig-Maximilian University of Munich, Germany

Program

Click here for program

Press release on the Symposium
Top-class international lecturers at Scheele symposium
2019 Scheele Award Winner Widely Celebrated

Participation fee

The early participation fee is 2 600 SEK for Industry delegates and 1 600 SEK for Academy delegates.

Fee for members in Apotekarsocieteten (Swedish Pharmaceutical Society), in Naturvetarna (Swedish Association of Professional Scientists), in Kemisamfundet (The Swedish Chemical Society) or in SwedenBIO is 2 100 SEK and for PhD students/Postdocs 1 000 SEK.  For registrations made after October 28, 2019 an additional 500 SEK will be added. Participation fee includes coffee and lunch.

Exhibition/partnership possibilities

Exhibition, 12 000 SEK exkl VAT
Including 1 free registration to the scientific program and exhibion stand/space for one roll-up.
When register choose ”Exhibitor”. We need to have a specific registration on every extra person that is interested to participate at the symposium from an exhibitor.

Time and Venue

The Scheele symposium takes place at Näringslivets hus, Storgatan 19 in Stockholm. The symposium starts at 09.15 with registration from 08.45 hrs. The symposium ends at 17.30 hrs. 

Program Committee

Birgitta Henriques Normark, Karolinska Institutet
Mohammad Bohlooly, Astra Zeneca
Bernt Eric Uhlin, Umeå universitet
Marcello Maresca, AstraZeneca
Susanna Abrahmsén-Alami, Apotekarsocietetens sektion för läkemedelsformulering
Lisa Bandholtz, Apotekarsocieteten